Takehiro Hirai
About
In The Last Decade
Takehiro Hirai
14 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 713
- Radiology, Nuclear Medicine and Imaging 414
- Molecular Biology 310
- Pulmonary and Respiratory Medicine 270
- Immunology 88
Countries citing papers authored by Takehiro Hirai
This map shows the geographic impact of Takehiro Hirai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Hirai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Hirai more than expected).
Fields of papers citing papers by Takehiro Hirai
This network shows the impact of papers produced by Takehiro Hirai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Hirai. The network helps show where Takehiro Hirai may publish in the future.
Co-authorship network of co-authors of Takehiro Hirai
This figure shows the co-authorship network connecting the top 25 collaborators of Takehiro Hirai. A scholar is included among the top collaborators of Takehiro Hirai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiro Hirai. Takehiro Hirai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 12 | |
| 6 | DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1 breakdown → | 767 |
| 7 | 45 | |
| 8 | 0 | |
| 9 | 89 | |
| 10 | 3 | |
| 11 | 72 | |
| 12 | [Pulmonary metastasis from breast cancer: a case report with 19-year disease-free interval]. | 2 |
| 13 | [Significance and problem of post-operative adjuvant chemotherapy for colorectal cancer]. | 1 |
| 14 | 4 | |
| 15 | Antitumor effect of 24R,25-dihydroxyvitamin D3. | 1 |
| 16 | 44 | |
| 17 | [Study on specificity of change of csf transferrin in motor neuron diseases (author's transl)]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.